🟢 Ultragenyx is trading 5% up today amid a biotech-sector rally

Ultragenyx is trading at $16.92, up +5.22%, with biotech-sector strength the clearest supported context.

• No verified company-specific announcement explains the October 27 move; reports point to the next earnings release in early November, not today.
• The move coincides with the supplied biotech-sector rally; XBI is up 2.18%, alongside broader market gains.
• A report about a possible $250 million offering has uncertain timing and price impact, so it does not establish the cause.